Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

China Pharma Holdings (CPHI) Interest & Investment Income: 2010-2024

Historic Interest & Investment Income for China Pharma Holdings (CPHI) over the last 15 years, with Dec 2024 value amounting to $6,641.

  • China Pharma Holdings' Interest & Investment Income fell 79.86% to $294 in Q3 2025 from the same period last year, while for Sep 2025 it was $3,125, marking a year-over-year decrease of 60.12%. This contributed to the annual value of $6,641 for FY2024, which is 0.59% up from last year.
  • As of FY2024, China Pharma Holdings' Interest & Investment Income stood at $6,641, which was up 0.59% from $6,602 recorded in FY2023.
  • In the past 5 years, China Pharma Holdings' Interest & Investment Income ranged from a high of $10,755 in FY2022 and a low of $3,035 during FY2021.
  • Over the past 3 years, China Pharma Holdings' median Interest & Investment Income value was $6,641 (recorded in 2024), while the average stood at $7,999.
  • In the last 5 years, China Pharma Holdings' Interest & Investment Income slumped by 79.38% in 2020 and then soared by 254.37% in 2022.
  • China Pharma Holdings' Interest & Investment Income (Yearly) stood at $5,675 in 2020, then crashed by 46.52% to $3,035 in 2021, then surged by 254.37% to $10,755 in 2022, then crashed by 38.61% to $6,602 in 2023, then increased by 0.59% to $6,641 in 2024.